Integral Health Asset Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773206

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 74 positions · Total reported value $1.17B · Top-10 concentration 33.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.2% · 35 new · 28 cut · 31 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 98.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.2% · vs SPY -13.3% · Prev Value $2.22B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.3% · vs SPY -2.5% · Latest Value $1.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Integral Health Asset Management, LLC disclosed 74 equity positions with a combined reported value of $1.17B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 33.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were THC ($60.91M), MLYS ($56.88M), VERA ($49.40M). By sector, the heaviest allocations are Health Care 92.6%, Consumer Staples 1.3%. Versus the prior quarter, allocation shifted toward Technology (+1.1pp), Other (+0.7pp) and away from Health Care (-1.4pp).

Versus the prior quarter, Integral Health Asset Management, LLC opened 35 new positions, trimmed 28 and fully exited 31, a turnover rate of 75.2% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2025 were NAMS ($28.44M), NVO ($22.20M), CNC ($14.27M).

Of the 31 positions fully exited versus the prior quarter, the largest were DXCM ($17.46M), GEHC ($14.81M), ETNB ($10.31M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • NAMS NEWAMSTERDAM PHARMA COMPANY · $28.44M
  • NVO NOVO-NORDISK A S · $22.20M
  • CNC CENTENE CORP DEL · $14.27M
  • DOCS DOXIMITY INC · $13.17M
  • ACLX ARCELLX IN · $12.31M
  • ASND ASCENDIS PHARMA A/S · $11.93M
  • NVST ENVISTA HOLDINGS CORPORATION · $11.20M
  • ISRG INTUITIVE SURGICAL INC · $11.18M

Fully Exited (vs previous quarter)

  • DXCM DEXCOM INC · prev qtr: $17.46M
  • GEHC GE HEALTHCARE TECHNOLOGIES I · prev qtr: $14.81M
  • ETNB 89BIO INC · prev qtr: $10.31M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $9.44M
  • BAX BAXTER INTL INC · prev qtr: $7.57M
  • ABBV ABBVIE INC · prev qtr: $7.42M
  • VRNA VERONA PHARMA PLC · prev qtr: $5.67M
  • ATYR ATYR PHARMA INC · prev qtr: $5.32M

Insider Transactions (Form 4)

Latest Integral Health Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Integral Health Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 90 positions worth $2.22B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-119048 (status: Approved), registered 2020-07-14
  • Regulatory AUM (Form ADV): $1.87B as of 2026-03-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: integralhlth.com

Portfolio Structure

  • 90 positions · $2.22B reported value (Q2 2026)
  • Top 10 holdings = 41.0% of reported value
  • Largest position: INSM (INSMED INC) at 7.7%
  • Average position size: $24.69M

Sector Tilt

  • Health Care 92.9%
  • Consumer Staples 5.1%
  • Industrials 1.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 25 added, 22 reduced, 24 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.6%
Technology 1.1%
Other 4.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 300.00K $60.91M 5.20%
5.20%
Add
2 1.50M $56.88M 4.86%
4.86%
Reduce
3 1.70M $49.40M 4.22%
4.22%
Add
4 750.00K $41.22M 3.52%
3.52%
Add
5 600.00K $35.02M 2.99%
2.99%
Reduce
6 1.15M $33.99M 2.90%
2.90%
Reduce
7 300.00K $29.29M 2.50%
2.50%
Reduce
8 1.00M $28.44M 2.43%
2.43%
New
9 50.00K $28.11M 2.40%
2.40%
Hold
10 1.60M $27.92M 2.38%
2.38%
Add
11 60.00K $27.36M 2.34%
2.34%
Add
12 200.00K $25.65M 2.19%
2.19%
Hold
13 200.00K $25.40M 2.17%
2.17%
Reduce
14 1.50M $24.33M 2.08%
2.08%
Add
15 300.00K $23.02M 1.97%
1.97%
Add
16 300.00K $22.86M 1.95%
1.95%
Reduce
17 220.00K $22.22M 1.90%
1.90%
Add
18 400.00K $22.20M 1.90%
1.90%
New
19 150.00K $21.06M 1.80%
1.80%
Hold
20 130.00K $20.40M 1.74%
1.74%
Reduce
21 2.00M $18.80M 1.61%
1.61%
Add
22 400.00K $18.68M 1.60%
1.60%
Add
23 85.00K $16.20M 1.38%
1.38%
Reduce
24 50.00K $16.16M 1.38%
1.38%
Reduce
25 800.00K $16.11M 1.38%
1.38%
Add
26 200.00K $15.55M 1.33%
1.33%
Hold
27 20.00K $15.26M 1.30%
1.30%
Reduce
28 200.00K $15.08M 1.29%
1.29%
Reduce
29 250.00K $14.86M 1.27%
1.27%
Add
30 100.00K $14.40M 1.23%
1.23%
Reduce
31 150.00K $14.29M 1.22%
1.22%
Reduce
32 400.00K $14.27M 1.22%
1.22%
New
33 180.00K $13.17M 1.12%
1.12%
New
34 500.00K $12.74M 1.09%
1.09%
Reduce
35 50.00K $12.67M 1.08%
1.08%
Add
36 150.00K $12.31M 1.05%
1.05%
New
37 60.00K $11.93M 1.02%
1.02%
New
38 450.00K $11.85M 1.01%
1.01%
Reduce
39 15.00K $11.59M 0.99%
0.99%
Add
40 90.00K $11.55M 0.99%
0.99%
Add
41 750.00K $11.35M 0.97%
0.97%
Add
42 550.00K $11.20M 0.96%
0.96%
New
43 25.00K $11.18M 0.95%
0.95%
New
44 65.00K $11.18M 0.95%
0.95%
Add
45 200.00K $10.94M 0.94%
0.94%
Add
46 575.00K $10.82M 0.92%
0.92%
New
47 900.00K $10.80M 0.92%
0.92%
Reduce
48 1.10M $10.62M 0.91%
0.91%
Add
49 550.00K $10.41M 0.89%
0.89%
Add
50 800.00K $10.12M 0.86%
0.86%
New

FAQ

What did Integral Health Asset Management, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, Integral Health Asset Management, LLC reported 74 equity positions worth $1.17B in aggregate; its largest disclosed positions were THC ($60.91M), MLYS ($56.88M), VERA ($49.40M).

How large is Integral Health Asset Management, LLC's portfolio?

Integral Health Asset Management, LLC reported $1.17B of long equity holdings across 74 positions as of 2025-Q3. Top-10 holdings account for 33.4% of reported value.

What is Integral Health Asset Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/integral-health-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →